Company: BNBX
Filing Date: 2025-11-04
Form Type: 424B5
Source: 0001104659-25-105958
Chunk: 25

Company: BNB PLUS CORP.
Filing Date: 2025-11-04
Form: 424B5
Chunk 25
---
2025 and excludes:

| · | 345 shares of common stock issuable upon exercise of options outstanding as of October 31, 2025, with a weighted average exercise price of $742.71 per share; |

| · | 199,928 restricted stock units (“RSUs”)                                                                                                 
 outstanding as of October 31, 2025;                                                                                                     
 ·                                                                                                                                       
 19,157,363 shares of common stock issuable upon exercise of warrants outstanding as of October 31, 2025, with a weighted average        
 exercise price of $4.22 per share (which includes (i) an aggregate of 2,948,441 Series A Warrants (as defined below); (ii) an           
 aggregate of 27,084 Series C Common Stock Purchase Warrants which were issued in a private placement on October 31, 2024; (iii) an      
 aggregate of 8,064,676 Series E Warrants, 1,986,634 Advisory Warrants, 403,236 Placement Agent Warrants (as defined below), and 209,119 
 Consultant Warrants; and (iv) an aggregate of 5,515,103 Pre-Funded Warrants); and                                                       |

Except as otherwise indicated, all information in this prospectus supplement
assumes no exercise of outstanding options and warrants.

| S-14 |

<div align='center'>RISK FACTORS</div>

Investment in our common stock involves a high degree of risk. In addition to the other information included or incorporated by reference in this prospectus supplement and the accompanying prospectus, you should carefully consider the risks described below and in the section titled “Risk Factors” in our Annual Report on Form 10-K for our most recent fiscal year filed with the SEC, subsequent Quarterly Reports on Form 10-Q, any amendment or updates thereto reflected in subsequent filings with the SEC, Exhibit 99.3to our Current Report on Form 8-K filed on October 1, 2025 and in other reports we file with the SEC that are incorporated by reference herein, before making an investment decision. The following risks are presented as of the date of this prospectus supplement and we expect that these will be updated from time to time in our periodic and current reports filed with the SEC, which will be incorporated herein by reference. Please refer to these subsequent reports for additional information relating to the risks associated with investing in our common stock.

The risks and uncertainties described therein and below could materially adversely affect our